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Abstract
Background: Frequently cited benefit-cost ratios suggest that interventions to improve neurodevelopment have
high economic returns when implemented during pregnancy and early childhood. However, there are many
challenges when primary care providers implement these interventions at scale, and it is unclear how many
research studies or programmes have examined cost-effectiveness and which methods were used. There are no
current scoping or systematic reviews which have assessed economic evaluations of interventions delivered by
primary care providers to improve child neurodevelopment.
Methods/design: The aim of this review is to describe the economic evaluations of interventions delivered by
primary care providers to improve neurodevelopment in children aged 0–4 years. Specific subgroup analyses will
include income level of country (high, middle and low); population type (universal vs targeted); time period when
intervention was implemented (antenatal vs infancy [0–11 months] vs early childhood [12–59 months]); and setting
(research study vs programmes evaluation at scale). All study designs will be included. The primary outcomes of
interest are cost per neurodevelopmental or cognitive health gain in children aged 0–4 years. All measures of cost,
neurodevelopment or cognitive function that have been previously validated as an appropriate test in this domain
will be included. Databases such as MEDLINE (OVID), PsycINFO (OVID), EMBASE (OVID), CINAHL, Cochrane Library
(including CENTRAL, DARE, HTA and NHS EED), Paediatric Economic Database Evaluation (PEDE) and WHO databases
and reference lists of papers will be searched for relevant articles. Five phases will be followed: identifying the research
question, identifying relevant studies, study selection, charting data and collating, summarising and reporting results.
We will present cost and effectiveness data descriptively.
Discussion: This review appears to be the first to be conducted in this area. The findings will be an important resource
for future systematic reviews on interventions that have a cost component. This information will be valuable for policy
makers and programmers who work in public health or primary care settings.
* Correspondence: karen.edmond@uwa.edu.au
1School of Paediatrics and Child Health, The University of Western Australia,
Perth, WA, Australia
4School of Paediatrics and Child Health, The University of Western Australia,
35 Stirling Highway, Crawley, WA 6009, Australia
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Edmond et al. Systematic Reviews  (2017) 6:59 
DOI 10.1186/s13643-017-0450-6
Introduction
Interventions delivered in early childhood have been
shown to have substantial and sustained impacts on
long-term cognitive and neurodevelopmental outcomes.
Frequently cited benefit-cost ratios from the USA sug-
gest that for every dollar invested in services for pre-
school age children, there will be a $2 to $2.60 return to
society [7, 8]. The economic return has been estimated
at between 15 and 17% for every dollar taking into
account crime, education and welfare savings and in-
creased taxes due to higher earnings [7, 8].
Primary care providers are health professionals who
work at the first level of the health service and are
trained in clinical care. They include community health
workers, Indigenous health workers, generalist nurses,
health visitors, midwives, child health nurses, general
practitioners and other primary care doctors. Primary
care providers routinely provide face to face ‘non-medi-
cinal’ interventions such as advice, counselling and the
promotion of behaviour change for their clients. Preg-
nant women, families and care givers of young children
receive anticipatory guidance, health promotion, health
education, promotional interviewing and motivational
interviewing. They also receive screening, surveillance
and ‘brief interventions’ (time-limited interventions im-
plemented by primary care providers that focus on prais-
ing and reinforcing or changing caregiver behaviour).
Delivery channels may include home visiting, clinic
visits, group programmes, telehealth, antenatal care and
child health checks. Examples include screening for
postnatal depression and developmental milestones, the
World Health Organization (WHO)/Unicef Care for
Child Development package [20], the WHO Thinking
Healthy programme [22] and the nurse family partner-
ship model for high-risk families [15, 17]. Many of these
programmes have been highly effective in improving
children’s long-term neurodevelopmental outcomes
when implemented in highly controlled research set-
tings. However, there are many challenges when imple-
menting these programmes at scale, and it is unclear
how many research studies or programmes have exam-
ined cost-effectiveness and which methods were used.
There are also increasing numbers of alternate chan-
nels available for delivery of interventions to reinforce
and change the behaviour of children’s care givers in-
cluding electronic and social media (e.g. biofeedback,
chat rooms, mass media, plain packaging, social market-
ing, websites, web boards and webinars). Face to face
access to primary care providers can be limited espe-
cially in remote areas; their services can be expensive to
maintain and their quality of care is variable. Reinforcing
and changing behaviour is also difficult and requires a
specific skill set, high quality training and a population
who are ‘ready to change’. Indeed, it has been suggested
that face to face encounters with mainstream primary
care providers should be restricted to acute care and tar-
geted screening and that behaviour change interventions
should be provided by other channels [17].
Systematic reviews have assessed the effect of medi-
cinal approaches to improving child neurodevelopment
such as vaccinations [4] and nutritional supplementation
including vitamin A [6] and iron [21]. ‘Non-medicinal’
systematic reviews have focused on interventions to pro-
mote access [14], combined impact of ‘packages’ of
interventions [12], maternal mental health interventions
[9, 16] and child weight management programmes [1].
However, no scoping reviews, inventories or narrative
assessments of cost and cost-effectiveness appear to have
been published. This information is important for health
professionals to make policy decisions and implement
programmes on a large scale.
Objectives
The aim of this review is to ‘scope’ , describe and provide
an inventory of the studies that have assessed the eco-
nomics of interventions delivered by primary care pro-
viders to improve child neurodevelopment in children
aged 0–4 years using scoping review methodology
[2, 3, 10]. Specific subgroup analyses will include income
level of country (high, middle and low); population type
(universal vs targeted); time period when intervention
was implemented (antenatal vs infancy [0–11 months]
vs early childhood [12–59 months]); and setting
(research study vs programme evaluation at scale) [19].
Methods
Protocol development
Our protocol is based on the scoping review methods
proposed by Arksey and O’Malley [2, 13]. This five stage
process includes identifying the research question, iden-
tifying relevant studies, study selection, charting data
and collating, summarising and reporting results.
Recommendations of the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses Protocols
(PRISMA-P) statement are provided [18] (Additional file
1). As this is a scoping review, we have not registered it
with PROSPERO.
Criteria for considering studies for inclusion
Types of studies
We will include all economic evaluations meeting the
eligibility criteria regardless of whether they are con-
ducted alongside an effectiveness intervention (e.g. a
randomised controlled trial (RCT). This will include full
economic evaluations (cost-effectiveness, cost-utility and
cost-benefit analysis), cost analyses and comparative
resource utilisation studies [11]. We will include pub-
lished abstracts if there is sufficient information to allow
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us to assess study eligibility and risk of bias. If sufficient
information is not available, the study will await assess-
ment pending the publication of the full trial report or
the provision of further information by trial authors.
Participants
All population groups will be included if they can be
accessed by mainstream primary care providers. This
will include pregnant women, families and their children
aged under 5 years in high, middle and low income
countries. Universal, targeted and high-risk groups will
be included. Studies focused on mothers or children
with specific disease entities such as malnutrition, HIV,
autism and post partum depression will be excluded and
considered as targeted high-risk groups.
Intervention
Interventions will include any non-medicinal interven-
tion implemented in the presence (i.e. face to face, not
in the waiting room) of a generalist primary care pro-
vider (health professional who is trained in clinical care,
has a recognised clinical qualification and works at the
first level of the health system, e.g. community health
workers, Indigenous health workers, generalist nurses,
health visitors, midwifes, child health nurses, general
practitioners and other primary care doctors). These in-
terventions will usually be motivational or educational in
nature and use counselling skills. They may include
anticipatory guidance, health promotion, health educa-
tion, promotional interviewing, motivational interview-
ing, screening and surveillance. Delivery channels may
include home visiting, child health checks, antenatal
care, group programmes and telehealth. We will specific-
ally exclude interventions that do not require the face to
face presence of a primary care provider such as inter-
ventions provided in the waiting room (e.g videos and
health promotion pamphlets). We will also exclude in-
terventions that involve medicinal products such as nu-
tritional supplementation, vaccinations and drug trials.
Control condition
Some studies will have a comparator group of other care
or standard care. We are aware that control groups may
vary substantially across studies. Thus, we will describe
all control groups as carefully as we describe the inter-
vention groups.
Outcomes
Our primary outcome measure will be cost per neu-
rodevelopmental or cognitive health gain in children
aged 0–4 years. This will often be reported as an
incremental cost-effectiveness ratio. We will also
include full details of all other cost measures. All
measures of neurodevelopmental or cognitive
function that have been previously validated as an
appropriate test in this domain will be included.
This will include general intelligence quotients and
subscales including cognitive, language, speech, fine
motor and gross motor development measured by
standard tools such as the Bayley Scales of Infant
and Toddler Development and the Griffiths Mental
Development Scales. Measures of executive function-
ing and adaptive functioning will also be included.
We will not include assessments of hearing or vision
development. We will also exclude social and emo-
tional development and child behavioural outcomes
from this review.
Search methods for identification of studies
Search strategy
The databases to be used for searching the relevant trials
include the Cochrane Central Register of Controlled Tri-
als (CENTRAL) (the Cochrane Library), MEDLINE
(Ovid), EMBASE (Ovid) and Cochrane Database of
Systematic Reviews, Health Technology Assessment
(HTA) Database, NHS Economic Evaluation Database
(NHS EED), Paediatric Economic Database Evaluation
(PEDE) and Database of Abstracts of Reviews of Effects
(DARE). An example of the MEDLINE search strategy is
in Additional file 2. We will also search clinical trial regis-
tries such as Clinical-Trials.gov (http://clinicaltrials.gov/),
International Standard Randomised Controlled Trial
Number (ISRCTN) (http://www.controlled-trials.com),
WHO International Clinical Trials Registry Platform
(http://who.int/ictrp/en/) and UK Clinical Research
Network Study Portfolio (http://www.nihr.ac.uk/research-
and-impact/nihr-clinical-research-network-portfolio/). The
search period will be from 2005 to 2016 (the most recent
10-year period) in all languages. Translation assistance will
be sought.
Searching other sources
We will hand search reference lists from relevant articles
chosen for potential inclusion in this review to identify
further relevant studies. We will contact authors of in-
cluded studies to determine whether there are any add-
itional studies published, ongoing or unpublished that
may be relevant. We will also search systematic review
reference lists to identify any potentially relevant studies.
Study selection
All titles and abstracts retrieved through the search
strategy will be reviewed independently by two authors
to identify studies that meet the inclusion criteria.
Inclusion criteria at the title and abstract review level
will be limited to any primary study reporting on pri-
mary care provider-related interventions to improve
child cognition or neurodevelopment. Exclusion criteria
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at this stage will be qualitative and opinion articles and
if the study clearly does not include children aged under
5 years or pregnant women.
Once articles have been identified, full-text articles will
be retrieved and independently assessed by two independ-
ent review authors. We will specifically look for assess-
ment of cost and cost effectiveness in the full-text articles
and will exclude all studies that do not assess cost or cost-
effectiveness. We will also assess articles for the exclusion
criteria as listed above including medicinal interventions
such as vaccination and nutritional supplementation and
studies that only assess hearing or vision. If there is any
disagreement, a third author will be asked to review the
article. Authors will also be contacted for further clarifica-
tion if necessary. We will document reasons for exclusion.
Endnote X7 will be used throughout the process.
Data extraction and management
Data will be collected by two independent reviewers
using a standardised data collection form. Authors will
be contacted for all missing data. Data collected from
each study will include
 Basic descriptors (country in which study was
conducted, year of publication, income level of
country—high, middle and low)
 Population type—universal, targeted (including full
details of the target group)
 Type of primary care provider—community health
worker, Indigenous health worker, generalist nurse,
health visitor, midwife, child health nurse, general
practitioner, other primary care doctor
 Intervention type—anticipatory guidance, health
promotion, health education, counselling,
promotional interviewing, motivational interviewing,
screening, surveillance, family partnership working
 Delivery channel—home visiting, group
programmes, clinic visits, child health checks,
antenatal care, telehealth, recall system, reminder
systems, quality improvement initiatives
 Intervention implementation period—antenatal,
infancy, early childhood
 Intervention frequency and duration
 Comparator group (e.g. full details of other care or
standard care)
 Child neurodevelopmental outcomes—general
intelligence quotients, subscales including cognitive,
language, speech, fine motor, gross motor
development, executive functioning, adaptive
functioning
 Age of child at outcome measurement
 Study design
 Methods used to collect cost data (e.g. WHO
CHOICE (Choosing Interventions that are Cost
Effective), OECD (Organisation for Economic
Co-operation and Development))
 Perspective of economic evaluation (societal, health
service)
 Type of economic evaluation (e.g. cost-effectiveness)
 Other important economic analyses: sensitivity
analyses, discounting
 Participant numbers in each group (numerators and
denominators)
Dealing with missing data
We will attempt to contact authors by email for any
missing data.
Data synthesis
Data will be reported in simple descriptive tables. We
will also assess sub-groups descriptively: income level of
country (high, middle and low); population type (univer-
sal vs targeted); time period when intervention was
implemented (antenatal vs infancy [0–11 months] vs
early childhood [12–59 months]); and setting (research
study vs programme evaluation at scale). We will assess
data using narrative approaches; no meta-analyses will
be performed.
Discussion
The findings of our review will be an important resource
for policy makers and programmers in a variety of differ-
ent settings. Our review will provide data about which
studies and trials have assessed cost and cost-
effectiveness of interventions to improve child
neurodevelopment and the cost of implementing pri-
mary care provider programmes in high, middle and low
income countries. We will provide up to date informa-
tion on the impact of population type (universal vs
targeted); time period when intervention was imple-
mented (antenatal vs infancy [0–11 months] vs early
childhood [12–59 months]); and the impact of setting
(research study vs programme evaluation at scale) on
cost and cost-effectiveness. In addition, some earlier
cost-effectiveness studies and systematic reviews have re-
ported very large clinical effect sizes raising a concern
about publication bias [5]. Our scoping review will help
to clarify this and other possible biases.
Our next steps include the assessment of other deliv-
ery channels that can improve child neurodevelopment
such as electronic and social media (e.g. biofeedback,
chat rooms, mass media, plain packaging, social market-
ing, websites, web boards and webinars) in high, middle
and low income settings. Policy makers and program-
mers will then be able to compare and contrast our in-
ventories and impacts. Our data will be able to be used
as input parameters by modellers who need to calculate
disability-adjusted life years (DALYs), quality-adjusted
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life years (QALYs), economic returns, benefit cost ratios,
cost per health gain and burden of disease in a variety of
different settings.
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